Compliance & TGA Regulations

Compliance & TGA Regulations – MOCA Health

At MOCA Health, we are fully committed to providing safe, high-quality medical cannabis products in line with the rigorous standards set by the Australian Therapeutic Goods Administration (TGA) and other regulatory bodies. Compliance with these regulations is a top priority in everything we do, from sourcing our products to ensuring that our patients receive the best care possible.

Adherence to TGA Regulations

MOCA Health operates under strict compliance with the TGA, Australia’s national regulatory authority for therapeutic goods. This ensures that all our medical cannabis products meet the necessary safety, efficacy, and quality standards before they are made available to healthcare providers and patients.

As a licensed wholesaler and importer of medical cannabis, MOCA Health follows the TGA’s guidelines for the manufacturing, labeling, and distribution of cannabis-based products. Our commitment to these regulations means that we ensure all products are thoroughly tested, accurately labeled, and fully traceable throughout the supply chain.

We also comply with the regulations around the prescribing and dispensing of medical cannabis through our telehealth service, which operates within the TGA’s approved framework for medical cannabis use. This guarantees that the treatment provided is safe, legal, and in the best interest of the patient.

Quality Assurance and Third-Party Testing

To ensure the highest standards of quality and safety, MOCA Health utilizes a range of quality assurance measures at every step of the production and supply process. Our cannabis products undergo rigorous testing in accredited laboratories to verify their purity, potency, and safety.

Each product batch is tested for the following:

• Cannabinoid Content: Our products are tested to ensure accurate levels of active ingredients such as THC, CBD, and other cannabinoids. This helps us maintain consistent potency across our product range.

• Pesticide and Contaminant Testing: All products are tested for potential contaminants, including pesticides, heavy metals, and residual solvents, to ensure they are safe for consumption.

• Microbial Testing: We conduct tests for microbial contamination, such as bacteria, fungi, and other harmful pathogens, to ensure our products meet the highest hygiene standards.

In addition to in-house testing, we work with third-party laboratories to conduct independent quality assessments. This provides an extra layer of assurance that our products meet all regulatory requirements and are safe for use by patients.

Patient Safety and Product Integrity

At MOCA Health, patient safety is our top priority. We ensure that all products are manufactured in state-of-the-art facilities and stored under optimal conditions to maintain their integrity throughout the supply chain.

We also take steps to educate healthcare providers and patients about the correct use of medical cannabis products, including proper dosing and potential side effects. By promoting patient education, we aim to reduce the risk of misuse and ensure that patients get the maximum benefit from their treatment.

Our focus on product integrity extends to the packaging and labeling of our cannabis products. Each product is clearly labeled with essential information, including cannabinoid content, dosage instructions, and safety warnings, making it easier for both patients and healthcare providers to use our products safely and effectively.

Click here for more information about approved conditions for medical cannabis in Australia.

Conclusion

MOCA Health is dedicated to adhering to the highest industry standards and regulatory requirements. Our commitment to TGA compliance, quality assurance, third-party testing, and patient safety ensures that we provide the best possible medical cannabis products to Australian patients. With our thorough approach to compliance and product integrity, healthcare providers and patients can trust MOCA Health to deliver safe, effective, and high-quality cannabis-based therapies.